lung cancer
Conditions
Interventions
None listed
Sponsors
National Center for Global Health and Medicine National College of Nursing, Japan
Tokyo University of Science Faculty of Science and Technology Department of Information Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: A person - with pathologically diagnosed lung cancer - who receives chemotherapy with the regimen of intravenous administration of more than one anti-cancer drugs - who receive chemotherapy twice or more - who can use a tablet to submit the self-evaluation of monitoring physical signs - who is more than 20 years old - whose ECOG Performance status (PS) ranges from 0 to 2 - who has no severe dysfunctions of major organs; bone marrow, heart, liver and kidney
Exclusion criteria
Exclusion criteria: A person - who has no confirmed diagnosis - who cannot receive the standard treatment of cancer due to complications - who will receive less than 80% of prescribed dose with respect to all anti-cancer drugs in regimen - who receives chemoradiotherapy; radiation therapy and simultaneous chemotherapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The rate of self care adherence which are calculated by counts of data submission days. | — |
Secondary
| Measure | Time frame |
|---|---|
| Correlation between selfcare adherence rate and depression rating scale at the start day - Coincidence of the evaluations of adverse events between by a patient and by the attending doctors. | — |
Countries
Japan
Contacts
Public ContactAKIKO TONOSAKI
National Center for Global Health and Medicine National College of Nursing, Japan
Outcome results
None listed